Sign in to continue:

Tuesday, March 31st, 2026

Author: Minichart

Telomir Pharmaceuticals Regains Nasdaq Compliance Following 2025 Annual Shareholders Meeting

Telomir Pharmaceuticals, Inc. Announces Nasdaq Compliance Fo...

Dominari Holdings Inc. Reports 487% Revenue Surge and Record Financial Growth in 2025

Dominari Holdings Inc. Reports Explosive 2025 Revenue Growth...

LightWave Acquisition Corp. 2025 Annual Report: Business Overview, Strategy, Management, and Financials

LightWave Acquisition Corp. 2025 Annual Report: Key Investor...